Skip to main content
Top
Published in: Obesity Surgery 9/2015

01-09-2015 | Original Contributions

The Impact of Bariatric Surgery on Diabetic Retinopathy: A Systematic Review and Meta-Analysis

Authors: Douglas Cheung, Noah J. Switzer, David Ehmann, Christopher Rudnisky, Xinzhe Shi, Shahzeer Karmali

Published in: Obesity Surgery | Issue 9/2015

Login to get access

Abstract

Background

Significant reductions in glucose control immediately post bariatric surgery in patients with longstanding poor glycemic control can lead to the paradoxical progression of diabetic retinopathy (DR) in susceptible individuals. Bariatric surgery results in dramatic and immediate diabetic control postoperatively. We aimed to systematically review the literature to assess the effect of bariatric surgery on DR.

Methods

A comprehensive search of electronic databases (e.g., MEDLINE, EMBASE, SCOPUS, Web of Science, and the Cochrane Library) was completed. All randomized controlled trials, non-randomized comparison study, and case series were included. Inclusion criteria included English-speaking studies, enrolling ≥5 patients, and contained ophthalmological data on outcome of DR pre- and post bariatric surgery. Two independently reviewers screened abstracts, reviewed full text versions of all studies classified, and extracted data. All comparison studies included in the meta-analysis were assessed independently by two reviewers for methodological quality using the Cochrane Risk of Bias (RoB) tools. Disagreements were resolved by re-extraction, or third-party adjudication. Where possible and appropriate, a meta-analysis was conducted.

Results

A total of 277 studies were identified using our search criteria for screening. Four primary studies (n = 148 patients) met our inclusion criteria and were included in the systematic review. These included no randomized controlled trials and four non-randomized case series.
Patients with no preoperative DR (n = 80), following bariatric surgery, an average of 92.5 ± 7.4 % remained disease free, while 7.5± 7.4 % of patients progressed to DR.
Patients with diabetic retinopathy preoperatively (n = 68), following bariatric surgery, an average of 57.4 ± 18.5 % of patients had no change, 23.5 ± 18.7 % of patients had progression, and 19.2 ± 12.9 % of patients had improvement in their disease.

Conclusions

Progression of diabetic retinopathy is a significant issue postoperatively following bariatric surgery. Patients with a diagnosis of DR prior to surgery are at increased risk of further progression in their disease and should receive adequate counseling and evaluation prior to undergoing a surgical procedure. However, the few primary studies in this systematic review limit any conclusion. Further studies are needed to further evaluate these results.
Literature
2.
go back to reference Ghoorah K, et al. Obesity and cardiovascular outcomes: a review. Eur Heart J Acute Cardiovasc Care. 2014: p. [Epub ahead of print]. Ghoorah K, et al. Obesity and cardiovascular outcomes: a review. Eur Heart J Acute Cardiovasc Care. 2014: p. [Epub ahead of print].
3.
go back to reference Petrovic MA et al. Correlation between metabolic controls and changes in retina in patients having diabetes. Med Pregl. 2014;67(1–2):49–54.PubMedCrossRef Petrovic MA et al. Correlation between metabolic controls and changes in retina in patients having diabetes. Med Pregl. 2014;67(1–2):49–54.PubMedCrossRef
4.
go back to reference Gray SP, Jandeleit-Dahm K. The pathobiology of diabetic vascular complications–cardiovascular and kidney disease. J Mol Med (Berl). 2014;92(5):441–52.CrossRef Gray SP, Jandeleit-Dahm K. The pathobiology of diabetic vascular complications–cardiovascular and kidney disease. J Mol Med (Berl). 2014;92(5):441–52.CrossRef
5.
go back to reference Gloy VL et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934.PubMedCentralPubMedCrossRef Gloy VL et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934.PubMedCentralPubMedCrossRef
6.
go back to reference Lannoo M, Dillemans B. Laparoscopy for primary and secondary bariatric procedures. Best Pract Res Clin Gastroenterol. 2014;28(1):159–73.PubMedCrossRef Lannoo M, Dillemans B. Laparoscopy for primary and secondary bariatric procedures. Best Pract Res Clin Gastroenterol. 2014;28(1):159–73.PubMedCrossRef
7.
go back to reference Aminian A et al. Risk prediction of complications of metabolic syndrome before and 6 years after gastric bypass. Surg Obes Relat Dis. 2014;10(4):576–82.PubMedCrossRef Aminian A et al. Risk prediction of complications of metabolic syndrome before and 6 years after gastric bypass. Surg Obes Relat Dis. 2014;10(4):576–82.PubMedCrossRef
8.
go back to reference Brethauer SA et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258(4):628–36. discussion 636–7.PubMedCentralPubMed Brethauer SA et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258(4):628–36. discussion 636–7.PubMedCentralPubMed
9.
go back to reference Heneghan HM et al. Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up. Surg Obes Relat Dis. 2013;9(1):7–14.PubMedCrossRef Heneghan HM et al. Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up. Surg Obes Relat Dis. 2013;9(1):7–14.PubMedCrossRef
10.
go back to reference Johnson BL et al. Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus. J Am Coll Surg. 2013;216(4):545–56. discussion 556–8.PubMedCrossRef Johnson BL et al. Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus. J Am Coll Surg. 2013;216(4):545–56. discussion 556–8.PubMedCrossRef
11.
go back to reference Leong WB, Taheri S. The role of bariatric surgery in the treatment of type 2 diabetes mellitus. J R Coll Physicians Edinb. 2012;42(3):194–8.PubMedCrossRef Leong WB, Taheri S. The role of bariatric surgery in the treatment of type 2 diabetes mellitus. J R Coll Physicians Edinb. 2012;42(3):194–8.PubMedCrossRef
12.
go back to reference Silva RA, Morton JM, Moshfeghi DM. Severe worsening of diabetic retinopathy following bariatric surgery. Ophthalmic Surg Laser Imag Retina. 2013;44 Online(6): p. E11-4. Silva RA, Morton JM, Moshfeghi DM. Severe worsening of diabetic retinopathy following bariatric surgery. Ophthalmic Surg Laser Imag Retina. 2013;44 Online(6): p. E11-4.
13.
go back to reference Mohite AAF, Shah S, Miras PR, et al. The effects of obesity surgery on diabetic retinopathy. Appetite. 2012;58(3):1171. Mohite AAF, Shah S, Miras PR, et al. The effects of obesity surgery on diabetic retinopathy. Appetite. 2012;58(3):1171.
14.
go back to reference Zhang X, et al. Diabetic macular edema: new concepts in patho-physiology and treatment. Cell Biosci. 2014;4(27): p. [Epub ahead of print]. Zhang X, et al. Diabetic macular edema: new concepts in patho-physiology and treatment. Cell Biosci. 2014;4(27): p. [Epub ahead of print].
15.
go back to reference Miras AD et al. Bariatric surgery does not exacerbate and may be beneficial for the microvascular complications of type 2 diabetes. Diabetes Care. 2012;35(12):e81.PubMedCentralPubMedCrossRef Miras AD et al. Bariatric surgery does not exacerbate and may be beneficial for the microvascular complications of type 2 diabetes. Diabetes Care. 2012;35(12):e81.PubMedCentralPubMedCrossRef
16.
go back to reference Thomas RL et al. Does bariatric surgery adversely impact on diabetic retinopathy in persons with morbid obesity and type 2 diabetes? A pilot study. J Diabetes Complications. 2014;28(2):191–5.PubMedCrossRef Thomas RL et al. Does bariatric surgery adversely impact on diabetic retinopathy in persons with morbid obesity and type 2 diabetes? A pilot study. J Diabetes Complications. 2014;28(2):191–5.PubMedCrossRef
17.
go back to reference Varadhan L et al. Bariatric surgery and diabetic retinopathy: a pilot analysis. Obes Surg. 2012;22(3):515–6.PubMedCrossRef Varadhan L et al. Bariatric surgery and diabetic retinopathy: a pilot analysis. Obes Surg. 2012;22(3):515–6.PubMedCrossRef
18.
go back to reference Leong WBTS. The progression of diabetic retinopathy post bariatric surgery. Diabetes. 2013;2013(62):A159. Leong WBTS. The progression of diabetic retinopathy post bariatric surgery. Diabetes. 2013;2013(62):A159.
19.
go back to reference Ros Ruiz S. Diabetic nephropathy: changes after diabetes surgery? Nutr Hosp. 2013;28 Suppl 2:57–65.PubMed Ros Ruiz S. Diabetic nephropathy: changes after diabetes surgery? Nutr Hosp. 2013;28 Suppl 2:57–65.PubMed
20.
go back to reference Hellgren KJ, Agardh E, Bengtsson B. Progression of early retinal dysfunction in diabetes over time: results of a long-term prospective clinical study. Diabetes. 2014;63(9):3104–11.PubMedCrossRef Hellgren KJ, Agardh E, Bengtsson B. Progression of early retinal dysfunction in diabetes over time: results of a long-term prospective clinical study. Diabetes. 2014;63(9):3104–11.PubMedCrossRef
21.
go back to reference Fante RJ, Gardner TW, Sundstrom JM. Current and future management of diabetic retinopathy: a personalized evidence-based approach. Diab Manag (Lond). 2013;3(6):481–94. Fante RJ, Gardner TW, Sundstrom JM. Current and future management of diabetic retinopathy: a personalized evidence-based approach. Diab Manag (Lond). 2013;3(6):481–94.
22.
go back to reference Salehi M, D’Alessio DA. Effects of glucagon like peptide-1 to mediate glycemic effects of weight loss surgery. Rev Endocr Metab Disord. 2014;15(3):171–9.PubMedCentralPubMedCrossRef Salehi M, D’Alessio DA. Effects of glucagon like peptide-1 to mediate glycemic effects of weight loss surgery. Rev Endocr Metab Disord. 2014;15(3):171–9.PubMedCentralPubMedCrossRef
23.
go back to reference Varadhan L et al. GLP-1 agonist treatment: implications for diabetic retinopathy screening. Diabetes Res Clin Pract. 2011;94(3):e68–71.PubMedCrossRef Varadhan L et al. GLP-1 agonist treatment: implications for diabetic retinopathy screening. Diabetes Res Clin Pract. 2011;94(3):e68–71.PubMedCrossRef
24.
go back to reference Varadhan L et al. The impact of improved glycaemic control with GLP-1 receptor agonist therapy on diabetic retinopathy. Diabetes Res Clin Pract. 2014;103(3):e37–9.PubMedCrossRef Varadhan L et al. The impact of improved glycaemic control with GLP-1 receptor agonist therapy on diabetic retinopathy. Diabetes Res Clin Pract. 2014;103(3):e37–9.PubMedCrossRef
25.
go back to reference Dahl-Jorgensen K et al. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study. Br Med J (Clin Res Ed). 1985;290(6471):811–5.CrossRef Dahl-Jorgensen K et al. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study. Br Med J (Clin Res Ed). 1985;290(6471):811–5.CrossRef
26.
go back to reference Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet. 1993;341(8856):1306–9.PubMedCrossRef Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet. 1993;341(8856):1306–9.PubMedCrossRef
27.
go back to reference Lauritzen T et al. Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet. 1983;1(8318):200–4.PubMedCrossRef Lauritzen T et al. Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet. 1983;1(8318):200–4.PubMedCrossRef
28.
go back to reference Parving HH et al. Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism. 1983;32(9):943–9.PubMedCrossRef Parving HH et al. Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism. 1983;32(9):943–9.PubMedCrossRef
29.
go back to reference Kowluru RA. Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes. 2003;52(3):818–23.PubMedCrossRef Kowluru RA. Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes. 2003;52(3):818–23.PubMedCrossRef
30.
go back to reference Stefanidis D et al. Revisional bariatric surgery: perioperative morbidity is determined by type of procedure. Surg Endosc. 2013;27(12):4504–10.PubMedCrossRef Stefanidis D et al. Revisional bariatric surgery: perioperative morbidity is determined by type of procedure. Surg Endosc. 2013;27(12):4504–10.PubMedCrossRef
Metadata
Title
The Impact of Bariatric Surgery on Diabetic Retinopathy: A Systematic Review and Meta-Analysis
Authors
Douglas Cheung
Noah J. Switzer
David Ehmann
Christopher Rudnisky
Xinzhe Shi
Shahzeer Karmali
Publication date
01-09-2015
Publisher
Springer US
Published in
Obesity Surgery / Issue 9/2015
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-014-1539-9

Other articles of this Issue 9/2015

Obesity Surgery 9/2015 Go to the issue